ALLERGAN USA, INC. for ALLERGAN USA, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2010 | $390,000 | Replaced |
| 1st Quarter - Amendment | Aug 6, 2010 | $570,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Health Issues HCR
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Medicare/Medicaid MMM
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Medical/Disease Research/Clinical Labs MED
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Budget/Appropriations BUD
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.